Registry of Lobbyists

Registration - In-house Organization

Innovative Medicines Canada / Médicaments novateurs Canada / David Renwick, Interim President

Registration Information

In-house Organization name: Innovative Medicines Canada / Médicaments novateurs Canada
Previous in-house organization names
Responsible Officer Name: David Renwick, Interim President 
Responsible Officer Change History
Initial registration start date: 2004-08-19
Registration status: Active
Registration Number: 956428-371

Associated Communications

Total Number of Communication Reports: 876

Monthly communication reports in the last 6 months: 16

Version 66 of 107 (2018-06-18 to 2018-06-28)

Version 66 of 107 (2018-06-18 to 2018-06-28)